Independent Director · BridgeBio Pharma, Inc. (BBIO)

Chair, Audit Committee

Andrea J. Ellis director compensation at BridgeBio (FY2025): $600K

Fiscal year 2025 director compensation for Andrea J. Ellis at BridgeBio Pharma, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 24, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Andrea J. Ellis’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Andrea J. Ellis and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

BridgeBio Pharma Director Compensation Table · all 5 fiscal years held
In US dollars, as BridgeBio Pharma reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$50,000$274,959$274,988—$599,947
FY2024$50,000$0$549,998$0$599,998
FY2023$50,000$0$549,995$0$599,995
FY2022$50,000$0$549,996$0$599,996
FY2021$18,705$0$1,199,998$0$1,218,702

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BridgeBio Pharma, Inc. DEF 14A filed April 24, 2026, accession 0001140361-26-016723, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BridgeBio Pharma, Inc. filed document, accession 0001140361-26-016723. Every figure is read from that document and cited to the page and table it appears in. Filed April 24, 2026.

Get the BridgeBio Pharma Board Governance Report

$599,947 Andrea J. Ellis, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 24, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

Committees

FY2025 · as the proxy prints them

Audit (Chair)

The rest of the BridgeBio Pharma board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Ali J. SatvatIndependent Director$599,947
Andrew W. LoIndependent Director$649,947
Andrew W. Lo, Ph.DIndependent Director$649,947
Charles Homcy, M.DDirector$1,124,114
Douglas A. DachilleIndependent Director$599,947
Eric Aguiar, M.DIndependent Director$599,947
Frank P. McCormick, Ph.D., F.R.S., D.ScDirector$1,099,947
Fred HassanLead Independent Director$599,947
Hannah A. Valantine, M.DIndependent Director$599,947
James C. MomtazeeIndependent Director$599,947
Jennifer E. CookIndependent Director$599,947
Neil Kumar, Ph.DDirector—
Randal W. Scott, Ph.DIndependent Director$599,947
Ronald J. DanielsIndependent Director$599,947

The full BridgeBio Pharma compensation record

free company brief

This page is one director within BridgeBio Pharma's record. The company brief lists every named executive and director, each linking to their own page.

Order BBIO

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report